2m 2m 2m 2m 2m 2m 2m
GRNWICH LIFESCI (GLSI)
NASDAQ
$22.98-$0.05 (-0.22%)
Price as of Jun 23, 2026 7:42 PM EDT- $348.6MMarket Cap
- 154.48%1-Year Change
- BiotechnologyIndustry
GRNWICH LIFESCI (GLSI)
$22.98-$0.05 (-0.22%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 2.96% | 433,860 | +62,396 (+14.38%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 2.44% | 357,844 | +7,700 (+2.15%) | Dec 31, 2024 |
BLACKROCK INC. | 2.10% | 308,909 | +252,450 (+81.72%) | Jun 30, 2024 |
N/A | 2.03% | 298,266 | +298,266 (+100.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 2.02% | 296,624 | +14,443 (+4.87%) | Dec 31, 2025 |
GEODE CAPITAL MANAGEMENT, LLC | 1.06% | 155,466 | +3,782 (+2.43%) | Mar 31, 2026 |
STATE STREET CORP | 0.91% | 133,875 | +36,098 (+26.96%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 1.98% | 290,302 | +81,047 (+27.92%) | Mar 31, 2026 |
iSHARES TRUST | 1.55% | 227,431 | -704 (-0.31%) | Mar 31, 2026 |
Invesco Exchange-Traded Fund Trust II | 1.19% | 174,535 | 0 (0.00%) | Jan 31, 2026 |
INVESCO EXCHANGE-TRADED FUND TRUST | 0.90% | 132,440 | 0 (0.00%) | Jan 31, 2026 |
COLLEGE RETIREMENT EQUITIES FUND | 0.55% | 80,595 | +79,943 (+99.19%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 0.47% | 68,418 | +25,205 (+36.84%) | Feb 28, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.25% | 37,199 | +1,615 (+4.34%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions17.6M (52.91%)
- Mutual Funds9.1M (27.47%)
- Insiders6.5M (19.62%)
- Other0 (0.00%)
Insider Transactions
- 19.62% (6.5M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $609.7MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Patel Snehal CEO and CFO | Buy | Jan 13, 2026 | $53,694.00 | 1,800 | $29.83 | 5.6M |
Patel Snehal CEO and CFO | Buy | Jan 12, 2026 | $79,866.00 | 2,900 | $27.54 | 5.6M |
Patel Snehal CEO and CFO | Buy | Dec 31, 2025 | $91,848.00 | 4,300 | $21.36 | 5.6M |
Patel Snehal CEO and CFO | Buy | Dec 18, 2025 | $51,742.00 | 4,100 | $12.62 | 5.6M |
Patel Snehal CEO and CFO | Buy | Nov 25, 2025 | $38,502.00 | 4,600 | $8.37 | 5.6M |
Patel Snehal CEO and CFO | Buy | Oct 31, 2025 | $21,298.00 | 2,300 | $9.26 | 5.6M |
Patel Snehal CEO and CFO | Buy | Apr 25, 2025 | $35,568.00 | 3,600 | $9.88 | 5.6M |
Patel Snehal CEO and CFO | Buy | Apr 17, 2025 | $48,492.00 | 5,400 | $8.98 | 5.6M |
Patel Snehal CEO and CFO | Buy | Apr 07, 2025 | $32,760.00 | 3,600 | $9.10 | 5.6M |
Patel Snehal CEO and CFO | Buy | Jan 03, 2025 | $44,030.00 | 3,400 | $12.95 | 5.5M |
Patel Snehal CEO and CFO | Buy | Jan 02, 2025 | $23,940.00 | 2,000 | $11.97 | 5.5M |
Patel Snehal CEO and CFO | Buy | Dec 31, 2024 | $27,264.00 | 2,400 | $11.36 | 5.5M |
Patel Snehal CEO and CFO | Buy | Dec 30, 2024 | $35,584.00 | 3,200 | $11.12 | 5.5M |
Thompson Jaye VP Clinical Reg Affairs | Award | Dec 24, 2024 | $0.00 | 149,818 | $0.00 | 299,636 |
Patel Snehal CEO and CFO | Award | Dec 24, 2024 | $0.00 | 1.1M | $0.00 | 2.2M |
Rothe Eric | Award | Dec 24, 2024 | $0.00 | 41,349 | $0.00 | 82,698 |
Hallock Kenneth | Award | Dec 24, 2024 | $0.00 | 41,349 | $0.00 | 82,698 |
Daugherty Frank Joseph Chief Medical Officer | Award | Dec 24, 2024 | $0.00 | 104,890 | $0.00 | 209,780 |
Patel Snehal CEO and CFO | Award | Dec 24, 2024 | $0.00 | 25,008 | $0.00 | 2.2M |
McWilliams David | Award | Dec 24, 2024 | $0.00 | 61,984 | $0.00 | 123,968 |